Names & News

Posted: August 2018 Leena Gandhi, MD, PhD, has become head of oncology for Eli Lilly and Company, where she will direct research of the company’s immuno-oncology products. Previously, she was director of thoracic medical oncology at New York University (NYU) Langone Medical Center LLC. Prior to joining NYU Langone and the Perlmutter Cancer Center, Dr.…

Posted: August 2018 Navneet Singh, MD, the IASLC’s Regent from India, has been appointed chair of the IDEA working group for the American Society of Clinical Oncology. Dr. Singh will serve a 2-year term. Dr. Singh is also on the IASLC’s Staging Committee, and he leads the multidisciplinary thoracic oncology group at PGIMER, where he…

Posted: August 2018 Julie R. Brahmer, MD, MSc, director of thoracic oncology program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, has been recognized as 2018 Oncologist of The Year by Continental Who’s Who, a business publisher. Dr. Brahmer directs the Kimmel Cancer Center on the Johns Hopkins Bayview…

Posted: June 2018 The 2018 Heine H. Hansen Award recipient was IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. The award was presented at the 2018 European Lung Cancer Congress (ELCC), sponsored by the European Society for Medical Oncology (ESMO) and the IASLC. Dr. Barlesi is professor of medicine at the University of Aix…

Posted: June 2018 IASLC past-president Frances Shepherd, MD, has been awarded the 2018 Canada Gairdner Wightman Award for outstanding career leadership in medicine and medical science. Dr. Shepherd is a professor in the Department of Medicine, Scott Taylor Chair in Lung Cancer Research, and senior staff physician at the Princess Margaret Cancer Centre. She has…

Posted: June 2018 Pasi A. Janne, MD, PhD, was awarded the Second AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award is given to a cancer researcher who has conducted highly meritorious laboratory, translational, or clinical cancer research anywhere in the world at a relatively early state in his…

Posted: June 2018 Primo N. Lara, Jr., MD, has been named director of the National Cancer Institute–designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists serving more than 10,000 new adult and pediatric patients yearly. As director, Dr. Lara will hold the Codman-Radke Chair in Cancer Research and will serve…

Posted: February 2018 Laurie E. Gaspar, MD, MBA, has been elected as the 2019- 2020 Treasurer of ASCO. Dr. Gaspar is Professor Emeritus in the Department of Radiation Oncology at the University of Colorado, with continued clinical interest in the management of brain tumors and lung cancer. She also conducts research in patient communication and…

New IASLC Foundation Board Member Posted: February 2018 Dr. Paoletti is the Chairman of the Board for Genmab, PsiOxus Therapeutics (Chairman of the Board), FORMA Therapeutics, and Nucana Biomed. He was formerly the first appointed president of GSK Oncology, where he was responsible for championing an organization of more than 2,000 professionals around the world…

Posted: February 2018 Howard A. “Skip” Burris III, MD, has been elected to serve as the 2019-2020 President of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2019. Dr. Burris is president of clinical operations and chief medical officer for Sarah Cannon, the Cancer Institute of HCA Healthcare. He is…